All In Biotech

Drug Trial Radar · NCT03395132

Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema

Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

68

Actual

Start

Jul 31, 2018

Primary completion

May 9, 2019

Study completion May 9, 2019

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
First posted
Jan 10, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 2 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The trial is designed to compare the efficacy and safety of Fucicort® Lipid cream with the combination treatment of Fucidin® cream followed by betamethasone (Lianbang Beisong®) cream, or Fucicort® Lipid cream vehicle, when applied twice daily for two weeks. The trial is designed to demonstrate that treatment with Fucicort® Lipid cream is not inferior to the combination treatment with the mono component drugs, Fucidin® cream followed by betamethasone (Lianbang Beisong®) cream and that treatment with Fucicort® Lipid cream is superior to the treatment with Fucicort® Lipid cream vehicle. This is a 3-arm, parallel group, active- and vehicle-controlled trial comparing the efficacy and safety after 14 days treatment of Fucicort® Lipid cream, to Fucidin® cream followed by betamethasone (Lianbang Beisong®) cream, or Fucicort® Lipid cream vehicle, in subjects with clinically infected AD/eczema.

Conditions

  • Infected Atopic Dermatitis/Eczema

Interventions

  • Fucicort® Lipid creamDrug

    The active ingredient of Fucicort® Lipid cream are Fusidic acid and betamethasone. The pack size of Fucicort® Lipid cream is 15g.

  • Fucidin® creamDrug

    The active ingredient of Fucidin® cream is Fusidic acid. The pack size of Fucidin® cream is 15g.

  • Fucicort® Lipid cream vehicleDrug

    The active ingredient of Fucicort® Lipid cream vehicle is the identical cream of Fucicort® Lipid cream but without the active ingredient. The pack size of Fucicort® Lipid cream vehicle is 15g.

  • betamethasone (Lianbang Beisong®) creamDrug

    The active ingredient of betamethasone (Lianbang Beisong®) cream is Betamethasone hydrate. The pack size of betamethasone (Lianbang Beisong®) cream is 15g.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percentage change in modified Eczema Area and Severity Index (m-EASI) on trunk and extremities at Day 15Time frame: from baseline to Day 15

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital, Capital Institute of Pediatrics

    Beijing, China

  • Beijing Children's Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • Guangdong General Hospital

    Guangzhou, Guangzhou, China

  • Tongji Hospital of Tongji Medical College of Huazhong Univ. of Science & Technology

    Wuhan, Hubei, China

  • Dermatology Hospital, China Academy of Medicine and Science

    Nanjing, Jiangsu, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China

  • The First Hospital of Dalian Medical University

    Dalian, Liaoning, China

  • The Second Hospital of Dalian Medical University

    Dalian, Liaoning, China

  • The Chinese People's Liberation Army General Hospital Of Northern Theater

    Shenyang, Liaoning, China

  • The People's Hospital of Liaoning Province

    Shenyang, Liaoning, China

  • Tangdu Hospital

    Xi'an, Shan'xi, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, China

  • Shanghai Huashan Hospital

    Shanghai, Shanghai Municipality, China

  • Children's Hospital of Shanghai

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.